First-in-Human Study of ICT01 in Patients With Advanced Cancer

Montefiore Medical Center, The Bronx

START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid

Hospital Universitario HM Sanchinarro, Madrid

Institut Bergonie, Bordeaux

Haut Leveque, Bordeaux

H. Lee Moffitt Cancer Center and Research Institute, Tampa

CHU Nantes, Nantes

Centre Hospitalier Lyon Sud, Lyon

Pitie-Salpetriere, Paris

US Oncology Research, Irving

Institut Curie, Paris

The University of Texas MD Anderson Cancer Center, Houston

Banner MD Anderson Cancer Center, Gilbert

CHU Poitiers, Poitiers

City of Hope Comprehensive Cancer Center, Duarte

University of Washington, Seattle

Yale Cancer Center, New Haven

Institut Jules Bordet, Brussels

Centre Lyon Berard, Lyon

CHU Lyon, Lyon

Institut Paoli-Calmettes, Marseille

Gustave Roussy, Paris

University Carl Gustav Carus Clinical Trial Unit, Dresden

universitatklinikum Wurburg, Würzburg

Vall d'Hebron Instiute of Oncology, Barcelona

NHS Greater Glasgow and Clyde, Beatson West of Scotland Cancer Centre, Glasgow

Institute of Cancer Research, London

Centre Antoine Lacassagne, Nice

START Barcelone HM Nou Delfos, Barcelona